(Reuters) - Novo Nordisk is pushing ahead with the launches of weight-loss drug Wegovy in Europe even as it struggles to keep up with demand. The ...
STORY CONTINUES BELOW THESE SALTWIRE VIDEOS - Novo Nordisk is pushing ahead with the launches of weight-loss drug Wegovy in Europe even as it struggles to keep up with demand. The Danish drugmaker is working to convince European governments and insurers to reimburse the drug, seeking to position it as more than a lifestyle drug.Wegovy was launched in the U.S. in June 2021 but it took Novo until December 2022 to make all doses available there because of an initial production outage.
The weekly injections are started at 0.25 milligrams of active ingredient semaglutide and gradually increased to the maintenance dose of 2.4 milligrams.Wegovy was made available in all dose strengths in Denmark in early 2023. A four-week supply of the maintenance dose costs 2,370.60 Danish crowns . The Danish ministry of health has said reimbursing Wegovy would cost the state as much as $4 billion each year.In Norway, Wegovy was launched in all dose strengths in early 2023. The four-week supply of the maintenance dose costs 2,775.30 Norwegian crowns .
The cost of the drug will not be reimbursed for about 90% of Germans covered by public health insurance plans, under a law that bans them from covering weight-loss drugs.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Factbox-Launches of Novo Nordisk's weight-loss drug Wegovy(Reuters) - Novo Nordisk is pushing ahead with the launches of weight-loss drug Wegovy in Europe even as it struggles to keep up with demand. The ...
Lire la suite »
Novo Nordisk launches weight-loss drug Wegovy in UKBy Maggie Fick LONDON (Reuters) - Novo Nordisk launched its weight-loss injection Wegovy in Britain on Monday, its second debut in Europe in just over ...
Lire la suite »
Novo Nordisk launches weight-loss drug Wegovy in UKBy Maggie Fick LONDON (Reuters) - Novo Nordisk launched its weight-loss injection Wegovy in Britain on Monday, its second debut in Europe in just over ...
Lire la suite »
Novo's Wegovy weight-loss drug will cost 149-299 pounds in UK -Simple Online PharmacyLONDON (Reuters) - Simple Online Pharmacy, a UK-based online pharmacy chain, told Reuters on Monday that it would sell Novo Nordisk's weight-loss drug ...
Lire la suite »
Novo's Wegovy weight-loss drug will cost 149-299 pounds in UK -Simple Online PharmacyLONDON (Reuters) - Simple Online Pharmacy, a UK-based online pharmacy chain, told Reuters on Monday that it would sell Novo Nordisk's weight-loss drug ...
Lire la suite »
European stocks rise on China optimism; Novo Nordisk scales new peak(Reuters) - European shares rose on Monday, echoing an upbeat mood in Asia as investors were optimistic that a series of stimulus from China will ...
Lire la suite »